5yr
Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast Cancer - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34256965/
Patient-reported HRQOL among patients with HR+/HER2- early breast cancer who were disease-free was high, with reported scores comparable to normative scores. These results improve our understanding of HRQOL among patients with early disease and may facilitate future studies examining the potential i ...
Key Points
• Implications: “Patient-reported HRQOL among patients with HR+/HER2– early breast cancer who were disease-free was high, with reported scores comparable to normative scores. These results improve our understanding of HRQOL among patients with early disease and may facilitate future studies examining the potential impact of adjuvant treatment and disease recurrence, including metastasis.”
• In the current multinational, survey-based study, 1110 patients with Stage I, II, and III HR+/HER2- breast cancer, receiving either adjuvant treatment or under postadjuvant surveillance,, were assessed for health-related quality of life (HRQOL).